Atopic dermatitis (AD) is a common chronic inflammatory skin disease. Malassezia, the predominant skin microbiota fungus, is considered to exacerbate AD, especially in a subset of patients with head and neck type AD (HNAD). In the present study, the relationship between AD and sensitization to Malassezia antigens was investigated.
Methods
We assessed 173 patients with AD. The severity of eczema was determined with Eczema Area and Severity Index (EASI); the type of AD, namely, head and neck type, was reported as well. The total serum IgE and specific IgE to Malassezia were determined and correlated with clinical picture of AD, sex, age, and the EASI.
Results
Total IgE was elevated in 77.7% of patients. Specific IgE to Malassezia was positive (≥0.35 kU/L) in 49.1% of patients. Men were significantly more often sensitized to Malassezia antigen (58% of men vs 42% of women; P value, 0.04). Concurrently, 58% of patients with HNAD versus 42% non-HNAD patients had higher levels of specific IgE to Malassezia, this difference being nearly significant (P value, 0.06). Patients with atopy were also more frequently sensitized to Malassezia. No significant relationship between EASI and the level of total IgE or specific IgE to Malassezia was observed.
Conclusions
In our population, IgE-mediated sensitization was found in up to 49% of all patients with AD, most common in men and in head and neck type.
Get full access to this article
View all access options for this article.
References
1.
ZhangE, TanakaT, TajimaM, et al.Anti-Malassezia-specific IgE antibodies production in Japanese patients with head and neck atopic dermatitis: relationship between the level of specific IgE antibody and the colonization frequency of cutaneous Malassezia species and clinical severity. J Allergy (Cairo), 2011; 2011: 645670.
2.
BergmannRL, EdenharterG, BergmannKE, et al.Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy, 1998; 28 (8): 965–970.
3.
BozekA, FisherA, FilipowskaB, et al.Clinical features and immunological markers of atopic dermatitis in elderly patients. Int Arch Allergy Immunol, 2012; 157 (4): 372–378.
GuptaAK, BatraR, BluhmR, et al.Skin diseases associated with Malassezia species. J Am Acad Dermatol, 2004; 51 (5): 785–798.
6.
De BenedettoA, KuboA, BeckLA. Skin barrier disruption: a requirement for allergen sensitization?. J Invest Dermatol, 2012; 132 (3 Pt 2): 949–963.
7.
EPAAC Study Group. de Benedictis FM, Franceschini F, Hill D, et al. The allergic sensitization in infants with atopic eczema from different countries. Allergy, 2009; 64 (2): 295–303.
8.
TokuraY. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci, 2010; 58 (1): 1–7.
9.
LaskeN, NiggemannB. Does the severity of atopic dermatitis correlate with serum IgE levels?. Pediatr Allergy Immunol, 2004; 15 (1): 86–88.
10.
VakirlisE, LazaridouE, TzellosTG, et al.Investigation of cytokine levels and their association with SCORAD index in adults with acute atopic dermatitis. J Eur Acad Dermatol Venereol, 2011; 25 (4): 409–416.
11.
SaltBH, BoguniewiczM, LeungDY. Severe refractory atopic dermatitis in adults is highly atopic. J Allergy Clin Immunol, 2007; 119 (2): 508–509.
12.
WilliamsH, FlohrC. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol, 2006; 118 (1): 209–213.
13.
Fölster-HolstR, PapeM, BussYL, et al.Low prevalence of the intrinsic form of atopic dermatitis among adult patients. Allergy, 2006; 61 (5): 629–632.
14.
KrathenRA, HsuS. Failure of omalizumab for treatment of severe adult atopic dermatitis. J Am Acad Dermatol, 2005; 53 (2): 338–340.
15.
KaminishiK, SomaY, KawaY, et al.Flow cytometric analysis of IL-4, IL-13 and IFN-gamma expression in peripheral blood mononuclear cells and detection of circulating IL-13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease. J Dermatol Sci, 2002; 29 (1): 19–25.
16.
CardonaID, ChoSH, LeungDY. Role of bacterial superantigens in atopic dermatitis: implications for future therapeutic strategies. Am J Clin Dermatol, 2006; 7 (5): 273–279.
17.
CotterillJA, CunliffeWJ, WilliamsonB, et al.Age and sex variation in skin surface lipid composition and sebum excretion rate. Br J Dermatol, 1972; 87 (4): 333–340.
18.
DarabiK, HostetlerSG, BechtelMA, et al.The role of Malassezia in atopic dermatitis affecting the head and neck of adults. J Am Acad Dermatol, 2009; 60 (1): 125–136.
19.
WongAW, HonEK, ZeeB. Is topical antimycotic treatment useful as adjuvant therapy for flexural atopic dermatitis: randomized, double-blind, controlled trial using one side of the elbow or knee as a control. Int J Dermatol, 2008; 47 (2): 187–191.
20.
SakiN, JowkarF, AlyaseenS. Comparison of sertaconazole 2% cream versus hydrocortisone 1% ointment in the treatment of atopic dermatitis. J Dermatolog Treat, 2013; 24 (6): 447–449.
21.
SelanderC, ZargariA, MöllbyR, et al.Higher pH level, corresponding to that on the skin of patients with atopic eczema, stimulates the release of Malassezia sympodialis allergens. Allergy, 2006; 61 (8): 1002–1008.
GuptaAK, KohliY, SummerbellRC, et al.Quantitative culture of Malassezia species from different body sites of individuals with or without dermatoses. Med Mycol, 2001; 39 (3): 243–251.
24.
NakabayashiA, SeiY, GuillotJ. Identification of Malassezia species isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjects. Med Mycol, 2000; 38 (5): 337–341.
25.
Sandström FalkMH, Tengvall LinderM, JohanssonC, et al.The prevalence of Malassezia yeasts in patients with atopic dermatitis, seborrhoeic dermatitis and healthy controls. Acta Derm Venereol, 2005; 85 (1): 17–23.
26.
SugitaT, TajimaM, AmayaM, et al.Genotype analysis of Malassezia restricta as the major cutaneous flora in patients with atopic dermatitis and healthy subjects. Microbiol Immunol, 2004; 48 (10): 755–759.
27.
SugitaT, TajimaM, TsubukuH, et al.Quantitative analysis of cutaneous Malassezia in atopic dermatitis patients using real-time PCR. Microbiol Immunol, 2006; 50 (7): 549–552.
28.
Schmid-GrendelmeierP, ScheyniusA, CrameriR. The role of sensitization to Malassezia sympodialis in atopic eczema. Chem Immunol Allergy, 2006; 91: 98–109.
29.
JohanssonC, SandströmMH, BartosikJ, et al.Atopy patch test reactions to Malassezia allergens differentiate subgroups of atopic dermatitis patients. Br J Dermatol, 2003; 148 (3): 479–488.
30.
KatoH, SugitaT, IshibashiY, et al.Detection and quantification of specific IgE antibodies against eight Malassezia species in sera of patients with atopic dermatitis by using an enzyme-linked immunosorbent assay. Microbiol Immunol, 2006; 50 (11): 851–856.
31.
CasagrandeBF, FlückigerS, LinderMT, et al.Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic atopic eczema. J Invest Dermatol, 2006; 126 (11): 2414–2421.
32.
WaerstedA, HjorthN. Pityrosporum orbiculare—a pathogenic factor in atopic dermatitis of the face, scalp and neck?. Acta Derm Venereol Suppl (Stockh), 1985; 114: 146–148.
33.
BayrouO, PecquetC, FlahaultA, et al.Head and neck atopic dermatitis and Malassezia-furfur-specific IgE antibodies. Dermatology, 2005; 211 (2): 107–113.
34.
KimTY, JangIG, ParkYM, et al.Head and neck dermatitis: the role of Malassezia furfur, topical steroid use and environmental factors in its causation. Clin Exp Dermatol, 1999; 24 (3): 226–231.
35.
DevosSA, van der ValkPG. The relevance of skin prick tests for Pityrosporum ovale in patients with head and neck dermatitis. Allergy, 2000; 55 (11): 1056–1058.
36.
NewellL, PolakME, PereraJ, et al.Sensitization via healthy skin programs Th2 responses in individuals with atopic dermatitis. J Invest Dermatol, 2013; 133 (10): 2372–2380.
37.
DarsowU, VielufD, RingJ. Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: a randomized, double-blind multicenter study. Atopy Patch Test Study Group. J Am Acad Dermatol, 1999; 40 (2 Pt 1): 187–193.
38.
Ramirez de KnottHM, McCormickTS, KalkaK, et al.Cutaneous hypersensitivity to Malassezia sympodialis and dust mite in adult atopic dermatitis with a textile pattern. Contact Dermatitis, 2006; 54 (2): 92–99.
39.
LintuP, SavolainenJ, KalimoK, et al.Stability of Pityrosporum ovale allergens during storage. Clin Exp Allergy, 1998; 28 (4): 486–490.
40.
ScalabrinDM, BavbekS, PerzanowskiMS, et al.Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol, 1999; 104 (6): 1273–1279.
41.
LangeL, AlterN, KellerT, et al.Sensitization to Malassezia in infants and children with atopic dermatitis: prevalence and clinical characteristics. Allergy, 2008; 63 (4): 486–487.
42.
KekkiOM, ScheyniusA, PoikonenS, et al.Sensitization to Malassezia in children with atopic dermatitis combined with food allergy. Pediatr Allergy Immunol, 2013; 24 (3): 244–249.
43.
Sandström FalkMH, FaergemannJ. Atopic dermatitis in adults: does it disappear with age?. Acta Derm Venereol, 2006; 86 (2): 135–139.
44.
FigueredoLA, CafarchiaC, DesantisS, et al.Biofilm formation of Malassezia pachydermatis from dogs. Vet Microbiol, 2012; 160: 126–131.
45.
PedrosaAF, LisboaC, RodriguesAG. Malassezia infections: a medical conundrum. J Am Acad Dermatol, 2014. Epub ahead of print 2014 Feb 22.
46.
BäckO, BartosikJ. Systemic ketoconazole for yeast allergic patients with atopic dermatitis. J Eur Acad Dermatol Venereol, 2001; 15: 34–38.
47.
SvejgaardE, LarsenPO, DeleuranM, et al.Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo. J Eur Acad Dermatol Venereol, 2004; 18: 445–449.
48.
SelanderC, EngblomC, NilssonG, et al.TLR2/MyD88-dependent and -independent activation of mast cell IgE responses by the skin commensal yeast Malassezia sympodialis. J Immunol, 2009; 182 (7): 4208–4216.
